✦ LIBER ✦

Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE

✍ Scribed by Ketlin V. Pinheiro; Vania T. M. Hungria; Elisabeth S. Ficker; Claudete J. Valduga; Carlos H. Mesquita; Raul C. Maranhão

Publisher: Springer
Year: 2005
Tongue: English
Weight: 282 KB
Volume: 57
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0090-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of a cholesterol-rich microem

Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease

✍ VaniaT.M. Hungria; MariaC. Latrilha; DeboraG. Rodrigues; SergioP. Bydlowski; Car 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 331 KB

Saquinavir enhances the mucosal toxicity

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

✍ Joseph A Sparano; Peter H Wiernik; Xiaoping Hu; Catherine Sarta; David H Henry; 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 690 KB

A randomized comparison of the efficacy

A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphoma

✍ Reena Nair; Gopal Ramakrishnan; Narendran N. Nair; Tapan K. Saikia; Purvish M. P 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

## BACKGROUND. Combination chemotherapy consisting of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleomycin (MACOP-B) has been frequently used for the treatment of non-Hodgkin's lymphoma. This randomized study was undertaken to assess the efficacy and toxicity of th

Application of the international prognos

Application of the international prognostic index in a study of chinese patients with non-hodgkin's lymphoma and a high incidence of primary extranodal lymphoma

✍ Tony S. Mok; Joyce Steinberg; Anthony T. Chan; Winnie M. Yeo; P. Hui; Thomas W. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 3 views

## Background: Chemotherapy containing anthracycline is the standard initial treatment for aggressive non-hodgkin's lymphoma (nhl), and the international prognostic index (ipi) is widely accepted as the standard tool for determining the prognosis of patients with this disease. however, the data on

Non-Hodgkin's lymphoma in Northern Israe

Non-Hodgkin's lymphoma in Northern Israel: A study of 481 patients with emphasis on ethnic-related patterns

✍ Yoram Cohen; Dr. Abraham Kuten; Menahem Ben-Shahar; Nissim Haim; Ron Epelbaum; Y 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

During the period between [1970][1971][1972][1973][1974][1975][1976][1977][1978][1979][1980][1981][1982][1983][1984] 481 patients with previously untreated non-Hodgkin's lymphoma were referred to the Northern Israel Oncology Center, Haifa. There were 264 (54.9%) Ashkenazi Jews, 123 (25.6%) non-Ashke

Effect of chemotherapy on resting energy

Effect of chemotherapy on resting energy expenditure in patients with non-Hodgkin's lymphoma results of a sequential study

✍ Jacques Delarue; Eric Lerebours; Herve Tilly; Agnes Rimbert; Patrick Hochain; Cl 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 3 views

This study compared the resting energy expenditure (REE) modifications observed during successive intensive identical chemotherapy courses in non-Hodgkin's lymphoma patients to assess indirectly the metabolic changes induced by the cytotoxic effect of drugs on the tumor. With this therapeutic regime